Sign Up to like & get
recommendations!
0
Published in 2018 at "Cancer research"
DOI: 10.1158/0008-5472.can-17-0985
Abstract: Although antiestrogen therapies are successful in many patients with estrogen receptor alpha-positive (ERα+) breast cancer, 25% to 40% fail to respond. Although multiple mechanisms underlie evasion of these treatments, including tumor heterogeneity and drug-resistant cancer…
read more here.
Keywords:
csc activity;
antiestrogen;
prolactin induced;
cancer ... See more keywords